国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

INVESTIGATION INTO BENEFICIAL EFFECT OF KETOCONAZOLE IN HYPERLIPIDEMIA

Upasana Bhalani, Pravin Tirgar

Cardiovascular diseases (CVDs) have been reckoned amongst the top reasons for early deaths in the country. One of the major risk factors for developing CVDs is hyperlipidemia, an elevated condition of lipid levels in the body. Hyperlipidemia has been known to speed up a process of hardening of the arteries called atherosclerosis that may prove fatal in the development of various CVDs. Many drugs are available in the market for treatment of hyperlipidemia. This study was done with an objective to have a better alternative for treating hyperlipidemia than the existing treatment. An anti-fungal drug ketoconazole was taken under studies for treating hyperlipidemia in High Fat Diet induced hyperlipidemic rats. With ketoconazole treatment there was a significant lowering of serum lipid levels similar to that of the standard drug atorvastatin. Thus the results helped to conclude that ketoconazole can be helpful in improving lipid profile in hyperlipidemic conditions.